Prelude Ideal
Payments companies reported to CMS as associated with Prelude Ideal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prelude Ideal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prelude Ideal
These are the largest totals companies reported as associated with Prelude Ideal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Palaniappan Annamalai | Panama City, FL | Vascular & Interventional Radiology | $1,383.58 |
| Paulrajan Manoharan | Mcallen, TX | Cardiovascular Disease | $1,064.66 |
| Prasanna Manjini Sengodan | Moberly, MO | Interventional Cardiology | $1,060.76 |
| Shekher Maddineni | Valhalla, NY | Vascular & Interventional Radiology | $786.97 |
| Ravi Rao | Titusville, FL | Cardiovascular Disease | $747.76 |
| Teresa Sclafani | Garden City, NY | Vascular & Interventional Radiology | $747.76 |
| Mohamed Sheta | Houston, TX | Nephrology (Internal Medicine) | $716.54 |
| Razvan Buciuc | Johnson City, NY | Diagnostic Radiology | $709.85 |
| Zahra Akhtar | Galveston, TX | Internal Medicine | $697.47 |
| George So | Torrance, CA | Diagnostic Radiology | $649.75 |
Prescribed Prelude Ideal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.